文献速递脊柱关节炎

银屑病关节炎患者疲劳数字评定量表的效度、区分度与应答定义

Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis.
PubMed 文献 · RMD Open · 2020-01-01

本研究基于两项银屑病关节炎随机临床试验数据,评估疲劳数字评定量表(NRS)的心理测量学特性并探索临床有意义变化的应答定义。结果显示重测信度良好(组内相关系数=0.829),与类似概念评估呈中至高度相关,疾病活动改善时疲劳严重程度降低且第12和24周持续一致;3分改善被确定为治疗12-24周后临床有意义改善的最佳阈值。

要点

  • 疲劳NRS在银屑病关节炎患者中重测信度良好(ICC=0.829)。
  • 疲劳NRS与其他类似概念评估呈中至高度相关,支持结构效度。
  • 治疗12-24周后疲劳NRS改善3分被视为临床有意义改善的最佳阈值。

核心结论

  • 疲劳NRS是用于银屑病关节炎患者的一种有效且具有反应性的患者报告结局工具。

研究设计与样本

  • 基于两项银屑病关节炎随机临床试验的疾病特异性临床医生报告和患者报告数据,评估疲劳NRS的重测信度、结构效度和反应性,并使用锚定法和分布法探索应答定义。

主要发现

  • 重测信度分析支持疲劳NRS在银屑病关节炎患者中的可重复性(组内相关系数=0.829)。
  • 基线及第2周疲劳NRS均值(标准差)分别为5.7(2.2)和5.7(2.4)。
  • 疲劳NRS与测量类似概念的其他评估之间显示中至高度相关(按Sackett标准),支持结构效度。
  • 当基础疾病活动改善时疲劳严重程度降低,且在第12和24周降低保持 consistent。
  • 治疗12-24周后,疲劳NRS改善3分被确定为显示临床有意义改善的最佳阈值。

关键数值与推荐

  • 疲劳NRS重测信度组内相关系数=0.829。
  • 基线疲劳NRS均值(标准差)=5.7(2.2),第2周=5.7(2.4)。
  • 治疗12-24周后疲劳NRS改善3分被确定为临床有意义改善的最佳应答定义。

临床怎么用

  • 疲劳NRS可用于临床试验和常规临床实践中评估银屑病关节炎患者的疲劳。
  • 治疗12-24周后疲劳NRS改善3分可作为临床有意义改善的参考阈值。

局限性

  • 需要在疾病活动度较低的状态以及其他更多样化种族群体中,对常规临床实践中的信度进行稳健验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study assessed the psychometric properties of the fatigue numeric rating scale (NRS) and sought to establish values for clinically meaningful change (responder definition). METHODS: Using disease-specific clinician-reported and patient-reported data from two randomised clinical trials of patients with psoriatic arthritis (PsA), the fatigue NRS was evaluated for test-retest reliability, construct validity and responsiveness. A responder definition was also explored using anchor-based and distribution-based methods. RESULTS: Test-retest reliability analyses supported the reproducibility of the fatigue NRS in patients with PsA (intraclass correlation coefficient=0.829). Mean (SD) values at baseline and week 2 were 5.7 (2.2) and 5.7 (2.4), respectively. Supporting construct validity of the fatigue NRS, moderate-to-large correlations with other assessments measuring similar concepts as measured by Sackett's conventions were demonstrated. Fatigue severity was reduced when the underlying disease activity was improved and reductions remained consistent at week 12 and 24. A 3-point improvement was identified as being optimal for demonstrating a level of clinically meaningful improvement in fatigue NRS after 12-24 weeks of treatment. CONCLUSIONS: Fatigue NRS is a valid and responsive patient-reported outcome instrument for use in patients with PsA. The established psychometric properties from this study support the use of fatigue NRS in clinical trials and in routine clinical practice. Robust validation of reliability for use in routine clinical practice in treating patients with active PsA in less active disease states and other more diverse ethnic groups is needed.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Gladman D, Nash P, Goto H, et al. Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis. RMD Open. 2020. PMID: 31958274. doi:10.1136/rmdopen-2019-000928

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。